tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Unichem Laboratories Faces Demand Notice from NPPA for Alleged Overcharging

Story Highlights
Unichem Laboratories Faces Demand Notice from NPPA for Alleged Overcharging

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest update is out from Unichem Laboratories Limited ( (IN:UNICHEMLAB) ).

Unichem Laboratories Limited has received a Demand Notice from the National Pharmaceutical Pricing Authority (NPPA) regarding alleged overcharging for three drugs between July 2013 and November 2018. The NPPA has imposed a total penalty of ₹1,77,09,079 under the Drug Price Control Order 2013. Despite these allegations, Unichem Laboratories, which sold its domestic formulation business in December 2017, has assessed that there will be no material impact on its financials, operations, or other activities. The company is currently evaluating legal options to address the demand notices.

More about Unichem Laboratories Limited

Average Trading Volume: 3,818

Technical Sentiment Signal: Hold

Current Market Cap: 34.02B INR

For detailed information about UNICHEMLAB stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1